rPFS was similarly improved in both the younger [ HR 0.45 ( 95 % CI 0.38-0 .53 ) , P < 0.001 ] and elderly patient cohorts [ HR 0.27 ( 95 % CI 0.20-0 .37 ) , P < 0.001 ] relative to placebo , as were time to PSA progression and PSA response .